Evidence map›Paper›PMID 39252862›Full record

ArticleContemporary clinical trials communications2024

Recruitment and retention of pediatric participants for pandemic preparedness research: Experience from the PREMISE EV-D68 Pilot Study.

Hai Nguyen-Tran, Alicen B Spaulding, Kevin Messacar, Matthew R Vogt, Perdita Permaul, Daniel C Douek, Abe Mittelman, Careese Thompson, Sandy Grubbs, Christine Magana and 1 more

Abstract read
In one paragraph

Article in Contemporary clinical trials communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. An RNA-to-RNA pipeline for rapid antiviral antibody development.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hai Nguyen-TranUniversity of Colorado School of Medicine & Children's Hospital Colorado, Department of Pediatrics, Aurora, CO, 80045, USA.
Alicen B SpauldingVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.
Kevin MessacarUniversity of Colorado School of Medicine & Children's Hospital Colorado, Department of Pediatrics, Aurora, CO, 80045, USA.
Matthew R VogtUniversity of North Carolina at Chapel Hill, School of Medicine, Department of Pediatrics, Chapel Hill, NC, 27599, USA.
Perdita PermaulWeill Cornell Medical College & New York-Presbyterian Hospital, Department of Pediatrics, New York, NY, 10021, USA.
Daniel C DouekVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.
Abe MittelmanVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.
Careese ThompsonUniversity of Colorado School of Medicine & Children's Hospital Colorado, Department of Pediatrics, Aurora, CO, 80045, USA.
Sandy GrubbsUniversity of North Carolina at Chapel Hill, School of Medicine, Department of Pediatrics, Chapel Hill, NC, 27599, USA.
Christine MaganaWeill Cornell Medical College & New York-Presbyterian Hospital, Department of Pediatrics, New York, NY, 10021, USA.
Michelle L HernandezUniversity of North Carolina at Chapel Hill, School of Medicine, Department of Pediatrics, Chapel Hill, NC, 27599, USA.

Funding

Human Antibody Cross-Reactivity in Non-Polio EnterovirusesR01AI169461 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Matthew R Vogt · 2022 to 2026
$3.1M
Human antibody modification of enterovirus D68 infectionK08AI156125 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI VOGT, MATTHEW R · 2021 to 2025
$900k
NIAID NIH HHS K08 AI156125NIAID NIH HHS R01 AI169461
6 · The paper itself

Abstract

Recruitment and retention are challenges for prospective pediatric cohort studies, particularly those involving serial venipunctures. We investigated factors underlying enrollment and retention in the Pandemic Response Repository through Microbial and Immune Surveillance and Epidemiology (PREMISE) Enterovirus D68 (EV-D68) Pilot Study, a multicenter prospective longitudinal cohort study assessing the utility of immunologic surveillance for pandemic preparedness. This study enrolls children ≤10 years for two blood draws, pre- and post-EV-D68 season, separated by 6-18 months. Overall, 174 children were enrolled in Cohort 1 of the study and 120 (69 %) of children completed the study, with follow-up blood samples obtained from 101 (58 %) of participants. Families were primarily motivated to participate by a desire to help other children, advance science, and better prepare for the next pandemic. Adding research blood draws to clinically indicated blood draws improved enrollment, and multiple study touch points facilitated retention. These findings can be applied to improve recruitment and retention in future pandemic preparedness efforts and longitudinal pediatric cohort studies.

Indexed as

Cohort studyPandemic preparednessPediatricRecruitmentRetention

Identifiers

PMID39252862
PMCPMC11381461

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.